
    
      Injection of a bispecific anti-CEA x anti-HSG antibody TF2 (120 nmoles) and 30 hours later
      IMP-288 peptide labeled with gallium-68 (3 to 6 nmoles/150 MBq). A TEP imaging acquisition is
      plannified 60 min after the 68-Ga injection.
    
  